Pr Anthony BUISSON (@buissonpr) 's Twitter Profile
Pr Anthony BUISSON

@buissonpr

ID: 1582764983527555074

calendar_today19-10-2022 16:06:09

18 Tweet

42 Followers

55 Following

Pr Anthony BUISSON (@buissonpr) 's Twitter Profile Photo
Pr Anthony BUISSON
@buissonpr

a year ago

Happy to publish long-term results of the REMSWITCH study in AP&T confirming that switching from IV to SC infliximab is safe and well-accepted for IBD patients treated with intensified IV regimen and providing practical algorithm to help IBD physicians to safely manage the switch